- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02011217
The Effects of Rye Crisp Bread on Appetite and Metabolic Function (S2RBAM)
December 9, 2013 updated by: Isabella Lee, Swedish University of Agricultural Sciences
The Effects of Rye Crisp Bread on Subjective Appetite and Metabolic Function After Short-term Consumption
The aim of this study is to contribute to a better understanding of how dietary fibre in rye affects appetite and metabolic processes.
We will evaluate how the intake of rye crisp breads affects appetite, insulin secretion and glucose levels in the blood in healthy humans.
We will also investigate microstructural properties of the crisp breads with microscopy, as well as to characterize the food products with respect to the content of dietary fibre and certain bioactive compounds.
The aim is also to try to elucidate how observed effects on appetite are related to changes in insulin and glucose levels, appetite related hormonal signals and microstructural properties to verify findings from previous studies.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The short-term effects (up to 4 hours after intake) of rye crisp breads on subjective appetite and metabolism will be evaluated using a randomized cross-over study design.
Each participant will consume three different breakfasts consisting of two different rye crisp breads and one wheat crisp bread on three different occasions separated by a 1 week wash-out period.
Participants will rate subjective appetite (satiety, hunger and desire to eat) by using a visual analogue scale (VAS) every 30 min during a 4-hour period, starting 30 min before breakfast.
Blood samples will be collected before breakfast and at regular intervals throughout the day for analysis of glucose, insulin and hormone levels.
Gastric emptying rate will also be evaluated using paracetamol as an indicator.
Glucose and hormonal responses will be related to subjective appetite and to differences in composition of the breakfasts.
Study Type
Interventional
Enrollment (Actual)
25
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Uppsala, Sweden, SE-751 85
- Paediatric Research Facility; The Children's Hospital at Uppsala University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Habitual breakfast eaters
Exclusion Criteria:
- Pregnancy, lactation or wishing to become pregnant during the study period
- Dieting
- Weightloss
- Eating disorder
- Hyperglycemic
- Hyperinsulinemic
- Thyroid disease
- Metabolic issues
- Diabetes
- Physical or psychological problems with eating
- Food intolerance/allergies to foods included in the study
- Intolerance/allergy to paracetamol
- Heavy smokers
- Recent or concurrent participation in a dietary intervention research study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Rye crisp bread A
|
In a randomized cross-over design each subject receive one of three iso-caloric breakfasts on three different occasions, separated by 1 week wash-out period.
In a randomized cross-over design each subject receive one of three iso-caloric breakfasts on three different occasions, separated by 1 week wash-out period.
|
Experimental: Rye crisp bread B
|
In a randomized cross-over design each subject receive one of three iso-caloric breakfasts on three different occasions, separated by 1 week wash-out period.
In a randomized cross-over design each subject receive one of three iso-caloric breakfasts on three different occasions, separated by 1 week wash-out period.
|
Experimental: Wheat crisp bread C
|
In a randomized cross-over design each subject receive one of three iso-caloric breakfasts on three different occasions, separated by 1 week wash-out period.
In a randomized cross-over design each subject receive one of three iso-caloric breakfasts on three different occasions, separated by 1 week wash-out period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Subjective Appetite Profiles during 4 hours
Time Frame: -30, 0, 30, 60, 90, 120, 150, 180, 210, 240 minutes
|
Subjective feelings of appetite (satiety, hunger and desire to eat) assessed by visual analogue scale (VAS).
|
-30, 0, 30, 60, 90, 120, 150, 180, 210, 240 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gastric Emptying Rate during 4 hours
Time Frame: -15, 15, 35, 65, 95, 125, 185, 230 minutes
|
Paracetamol (1 g) taken with breakfast.
The appearance of paracetamol in the blood is directly related to the rate of gastric emptying.
|
-15, 15, 35, 65, 95, 125, 185, 230 minutes
|
Hormonal Responses during 4 hours
Time Frame: -15, 15, 35, 65, 95, 125, 185, 230 minutes
|
Glucagon, glucagon-like peptide-1 (GLP-1), glucose-dependent insulino-tropic polypeptide (GIP), peptide YY (PYY), cholecystokinin (CCK), leptin and ghrelin are measured in plasma samples.
|
-15, 15, 35, 65, 95, 125, 185, 230 minutes
|
Glucose and Insulin Responses during 4 hours
Time Frame: -15, 15, 35, 65, 95, 125, 185, 230 minutes
|
Glucose and insulin are measured in plasma samples.
|
-15, 15, 35, 65, 95, 125, 185, 230 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Rikard K Landberg, Ass. Prof., Swedish University of Agricultural Sciences
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2013
Primary Completion (Actual)
September 1, 2013
Study Completion (Actual)
September 1, 2013
Study Registration Dates
First Submitted
November 6, 2013
First Submitted That Met QC Criteria
December 9, 2013
First Posted (Estimate)
December 13, 2013
Study Record Updates
Last Update Posted (Estimate)
December 13, 2013
Last Update Submitted That Met QC Criteria
December 9, 2013
Last Verified
December 1, 2013
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- SLU-IL-S2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Appetite Regulation
-
Universitaire Ziekenhuizen KU LeuvenUnknownAppetite RegulationBelgium
-
Unilever R&DCompleted
-
UMC UtrechtCompleted
-
Universitaire Ziekenhuizen KU LeuvenUnknownAppetite RegulationBelgium
-
Swedish University of Agricultural SciencesUppsala UniversityCompletedAppetite RegulationSweden
-
KU LeuvenRecruitingAppetite Regulation | Energy IntakeBelgium
-
University of ParmaCompletedCognition | Eating Behavior | Regulation, AppetiteItaly
-
University of TorontoCompletedGlucose Metabolism | Appetite Regulation | HealthCanada
-
InQpharm GroupCompletedAppetite Regulation | Energy Intake | Appetite SuppressionGermany
-
Maastricht University Medical CenterWageningen University and ResearchCompleted
Clinical Trials on Rye crisp bread B
-
Swedish University of Agricultural SciencesUppsala UniversityCompleted
-
University of Eastern FinlandVTT Technical Research Centre of FinlandCompletedGlucose Metabolism Disorders | Inflammation | Intestinal Disorder
-
Oy Karl Fazer AbCompletedIrritable Bowel SyndromeFinland
-
Swedish University of Agricultural SciencesGood Food Practice, Sweden; Lantmännen R&DCompleted
-
Chalmers University of TechnologySahlgrenska University Hospital, SwedenCompletedAnaemia | Iron Bioavailability
-
Swedish University of Agricultural SciencesGood Food Practice, Sweden; Lantmannen Research and DevelopmentUnknown
-
University of HelsinkiFazer GroupUnknownBlood Glucose Concentration
-
Marjukka KolehmainenWageningen University; VTT Technical Research Centre, FinlandCompletedObesity | Metabolic Syndrome | Impaired Glucose Tolerance | Impaired Fasting GlucoseFinland
-
Swedish University of Agricultural SciencesUppsala UniversityCompletedAppetite RegulationSweden
-
Quadram Institute BioscienceNorfolk and Norwich University Hospitals NHS Foundation TrustCompleted